TGFB1 and pulmonary fibrosis: In contrast, previous studies showed increased TGF-β1 blood concentrations in COVID-19 [30] and suggested an involvement of this cytokine in the early pathogenesis of the disease and the development of clinical sequelae [29,30] such as extracellular matrix degradation and pulmonary fibrosis as serious consequences of COVID-19.